Clinical Burden and Unmet Therapeutic Needs in Patients with Advanced and Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Clinical Burden and Unmet Therapeutic Needs in Patients with Advanced and Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

How Effective is the Current Management Arsenal? What is the Latest Trial-Based Evidence for Efficacy and Safety of Immune Checkpoint Inhibition for CSCC?


Published

March 25, 2019

Created by

CMEducation Resources symposium

Related Presenters

Todd Schlesinger, MD, FAAD

Todd Schlesinger, MD, FAAD

Director, Dermatology and Laser Center of Charleston Clinical Research Center of the Carolinas Clinical Instructor, University at Buffalo Department of Dermatology Assistant Clincal Professor, Medical University of South Carolica Department ...